insights_auto
Why is TSHA down 2.51%?
Dive Deeperchevron_right
TSHA:NASDAQ
Taysha Gene Therapies Inc
$4.67
arrow_downward
-2.51%(-0.12) 1D
$4.67
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TSHA...
Open
$4.88
High
$4.88
Low
$4.66
Mkt. cap
1.52B
Avg. vol.
3.09M
Volume
4.66M
52-wk high
$7.30
52-wk low
$3.06
EPS
-$0.41
Beta
1.19
Shares outstanding
325.83M
No. of employees
99
Open
$4.88
High
$4.88
Low
$4.66
Mkt. cap
1.52B
Avg. vol.
3.09M
Volume
4.66M
52-wk high
$7.30
52-wk low
$3.06
EPS
-$0.41
Beta
1.19
Shares outstanding
325.83M
No. of employees
99
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
Taysha Gene Therapies (TSHA) Drops 6.5% as Gene Therapy Stock Approaches Key Support at $5.69 - Stock News
https://www.dars.gov.et/
·
2 months ago
TSHA Q1 2026 Earnings: Wider-Than-Expected Loss Reflects Pre-Revenue Stage, Stock Rises on Pipeline Optimism - Next Quarter Guidance
About Taysha Gene Therapies Inc
CEO-
Employees99
Founded2019
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitetayshagtx.com